TechCrunch says Build Mode breaks down a Startup Battlefield pitch
TechCrunch says Nephrogen CEO Demetri Maxim and pitching researcher Eike Gerhardt explore how to explain complex biotech, establish credibility and handle investor questions.
TechCrunch says Nephrogen CEO Demetri Maxim and pitching researcher Eike Gerhardt explore how to explain complex biotech, establish credibility and handle investor questions.
TechCrunch describes a Build Mode episode examining Maxim’s Startup Battlefield pitch after his second-place finish in 2025. Gerhardt’s advice includes simplifying technical ideas without oversimplifying and treating investor Q&A as a second pitch. TechCrunch also draws a parallel between pitching and competitive skiing, citing Maxim’s advice to turn fear into excitement.
19.1K
1 post, first seen 4d ago
TechCrunch says Nephrogen CEO Demetri Maxim and pitching researcher Eike Gerhardt explore how to explain complex biotech, establish credibility and handle investor questions.
TechCrunch describes a Build Mode episode examining Maxim’s Startup Battlefield pitch after his second-place finish in 2025. Gerhardt’s advice includes simplifying technical ideas without oversimplifying and treating investor Q&A as a second pitch. TechCrunch also draws a parallel between pitching and competitive skiing, citing Maxim’s advice to turn fear into excitement.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet
Not enough discussion yet.
No sentiment analysis available yet.